A new wave of viral outbreaks has sparked global concern. The ‘Bleeding Eye’ virus, formally known as the Marburg virus, has claimed over 15 lives in Africa, infecting hundreds more. Travelers to the UK and Africa have been cautioned against the deadly disease as it threatens to spread further. Meanwhile, the ongoing transmission of Mpox and Oropouche viruses in various countries has added to the unease.
The Alarming Spread of Marburg Virus
Dubbed the ‘Bleeding Eye’ virus due to its distressing symptom of ocular bleeding, Marburg is among the deadliest pathogens known, with a 50% fatality rate. Reports indicate the virus has killed 15 people in Rwanda, and fears loom over its spread to other African nations struggling to contain similar outbreaks.
Marburg spreads through contact with infected blood, body fluids, or mucous membranes. Its symptoms emerge suddenly after an incubation period of 2–21 days, including:
- High fever
- Intense headaches
- Extreme fatigue and muscle pain
By the third day, additional symptoms such as severe diarrhea, abdominal cramping, and nausea appear. By day five, patients may experience:
- Bleeding from eyes, gums, nose, and other orifices
- Internal hemorrhaging
- Disorientation and shock
Patients often succumb within eight to nine days due to massive blood loss or organ failure. The virus is especially risky for those in proximity to bat colonies or spending time in caves.
Mpox: A Growing Threat Beyond Africa
Mpox, previously confined to central African nations, has surfaced in Burundi, Uganda, Kenya, and the Democratic Republic of Congo, among others. Alarmingly, the UK has reported five cases of the more severe Mpox clade 1 this year. One recent patient had returned from Uganda, and others were found within a single household in London.
Mpox symptoms typically surface 21 days after exposure and include:
- A blister-like rash on the face, palms, feet, and genital areas
- Muscle and joint pain
- Fever, swollen glands, chills, and headaches
Professor Susan Hopkins from the UK Health Security Agency emphasized the risk of household transmission, urging vigilance. Although the overall risk to the UK remains low, authorities advise travelers to avoid close contact with symptomatic individuals.
Precautions Against Mpox
Travelers are urged to follow strict hygiene measures:
- Avoid physical contact with those displaying rashes or flu-like symptoms
- Wash hands frequently
- Use hand sanitizers
With no pre-travel Mpox vaccine available, individuals, especially pregnant or immunocompromised travelers, should consult healthcare professionals before embarking on international trips. Travel health insurance is a must-have for added safety.
Oropouche: A Silent Menace in South America and the Caribbean
Oropouche virus, transmitted through midge bites, has infected over 10,000 people this year across Brazil, Bolivia, Colombia, and other countries, including tourist hotspots in the Caribbean. Though fatal cases are rare, the virus has no specific treatment or vaccine.
Symptoms usually appear 3–10 days post-infection and last about a week, including:
- Fever and chills
- Nausea and vomiting
- Joint and muscle pain
- Rash and headache
What Lies Ahead?
The concurrent outbreaks of Marburg, Mpox, and Oropouche have underscored the fragility of global health systems. Travelers must remain vigilant, adhering to health guidelines and avoiding high-risk areas whenever possible. While authorities worldwide work to contain these outbreaks, proactive measures remain the best defense against these life-threatening pathogens.
Stay informed, stay cautious, and prioritize your health when planning your next journey.
